News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
ImaRx Therapeutics Sets IPO At 5 Million Shares At $10-12/Share
September 8, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Sept 8 (Reuters) - ImaRx Therapeutics Inc. on Friday set its planned initial public offering at 5 million shares at an estimated price of $10 to $12 each.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Collaboration
GSK Makes $400M+ RNA Play With CAMP4 Collab, Targets Neuro, Kidney Diseases
December 18, 2025
·
1 min read
·
Tristan Manalac
China
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour
December 17, 2025
·
1 min read
·
Tristan Manalac
Artificial intelligence
Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab
December 17, 2025
·
1 min read
·
Tristan Manalac
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
December 17, 2025
·
3 min read
·
Jennifer Smith-Parker
